OncologyOncology/Foot & Ankle

Synovial Sarcoma of Foot

Oncology
Intermediate
6 min
High Yield
synovial sarcomasoft tissue sarcomaSYT-SSX translocationbiopsy principleswide resectionlimb salvagebelow knee amputationstagingneoadjuvant radiotherapyfoot mass
6:00
Start the timer to simulate exam conditions

Synovial Sarcoma of Foot

Clinical Scenario

A 15-year-old male presents with a slowly enlarging lump on the lateral border of his right foot that he first noticed 6 months ago. It has been gradually increasing in size and has recently become mildly painful. He is otherwise fit and well with no significant medical history.

History:

  • 6-month history of painless lump, now mildly tender
  • No history of trauma
  • Gradual increase in size (initially marble-sized, now golf ball-sized)
  • No constitutional symptoms (no weight loss, night sweats, fevers)
  • No previous skin lesions or radiation exposure
  • No family history of malignancy
  • Full-time student, plays football recreationally

Examination Findings:

  • 4 x 3 cm firm, non-fluctuant mass on lateral border of right foot
  • Located over 5th metatarsal region
  • Not attached to skin, moves slightly with underlying tissues
  • Non-tender to palpation
  • No overlying skin changes
  • No palpable regional lymphadenopathy (inguinal nodes)
  • Full range of motion of ankle and foot
  • Normal neurovascular examination distally
  • Contralateral foot normal

Investigations

Laboratory Results

Imaging

Plain X-ray Right Foot:

  • Soft tissue mass visible adjacent to 5th metatarsal
  • Calcification within the mass (~30% of synovial sarcomas show calcification)
  • No bone destruction or periosteal reaction
  • No obvious bone involvement

MRI Right Foot with Gadolinium:

  • 4.2 x 3.1 x 2.8 cm heterogeneous soft tissue mass
  • Located in subcutaneous tissue adjacent to 5th metatarsal
  • T1: Intermediate signal, iso-intense to muscle
  • T2: Heterogeneous high signal with areas of low signal ("triple sign" or "bowl of grapes" appearance)
  • Gadolinium: Heterogeneous enhancement
  • Well-defined margins but no true capsule
  • Abuts the 5th metatarsal periosteum but no cortical invasion
  • Displaces but does not encase lateral plantar neurovascular bundle
  • No skip lesions

CT Chest (Staging):

  • No pulmonary metastases
  • No mediastinal lymphadenopathy

Histopathology

Core Needle Biopsy Result:

  • Biphasic synovial sarcoma
  • Epithelial and spindle cell components present
  • Immunohistochemistry: CK7+, EMA+, bcl-2+, TLE1+
  • FISH positive for SYT-SSX translocation t(X;18)
  • Grade: High grade (FNCLCC Grade 3)

Questions & Model Answers

Q

What is your differential diagnosis for a soft tissue mass in the foot of an adolescent, and what features suggest synovial sarcoma?

Q

Describe the appropriate biopsy technique for this suspected soft tissue sarcoma.

Q

This is confirmed as synovial sarcoma. What is the pathognomonic genetic finding and how is synovial sarcoma staged?

Q

What are the surgical options for this patient and what factors influence limb salvage versus amputation?

Q

What is the role of adjuvant therapy in synovial sarcoma?

Q

What is the prognosis and follow-up protocol for this patient?


Key Teaching Points

ConceptDetail
Age GroupMost common STS in adolescents/young adults
Genetic Markert(X;18) SYT-SSX translocation is pathognomonic
MisnomerDoes NOT arise from synovium despite name
Calcification30% show calcification on X-ray (rare in other STS)
ChemosensitiveMore responsive to chemo than most STS
BiopsyBy treating surgeon, longitudinal, tract excisable
SurgeryWide margins (>1cm); ray amputation often sufficient in foot

Common Examiner Follow-up Questions

  1. "What is clear cell sarcoma and why is it important in the foot?"

    • Also called "melanoma of soft parts"
    • Involves tendons and aponeuroses
    • Predilection for foot and ankle
    • S100 positive, HMB45 positive (like melanoma)
    • Has EWSR1-ATF1 translocation
    • Highly aggressive, poor prognosis
  2. "What are Mankin's principles of biopsy?"

    • Study showed 3x higher error rate at referring hospitals
    • Biopsy by treating surgeon
    • Longitudinal incision
    • Through muscle not between compartments
    • Track must be excisable
    • Avoid haematoma
  3. "What is the FNCLCC grading system?"

    • French grading system for soft tissue sarcomas
    • Based on: Differentiation, Mitotic count, Necrosis
    • Grade 1 (low), Grade 2 (intermediate), Grade 3 (high)
    • Predicts metastatic risk